1662TiPVOYAGER: An open-label, randomised, phase III study of avapritinib vs regorafenib in patients (pts) with locally advanced (adv) metastatic or unresectable gastrointestinal stromal tumour (GIST). (23rd October 2018) - Bauer, S; George, S; Kang, Y-K; Tap, W D; Zhou, T; Picazio, N; Boral, A L; Heinrich, M